Atlas Trials

Somatostatinoma

12 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Somatostatinoma

RecordFirmDate
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors (NCT02259725)University of Southern California2016-08-16
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer (NCT02273752)Emory University2014-11-01
Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors (NCT02108782)Academic and Community Cancer Research United2014-10-01
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery (NCT02031536)ECOG-ACRIN Cancer Research Group2014-04-10
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors (NCT01824875)ECOG-ACRIN Cancer Research Group2013-08-08
Comparative Study of Sensitivity of Ga-DOTATOC PET vs Octreoscan SPECT + CT (NCT01869725)Sue O'Dorisio2013-04-01
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors (NCT01525082)Shaheen Shagufta2012-12-01
Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00131911)National Cancer Institute (NCI)2005-06-01
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors (NCT00655655)Mayo Clinic2004-12-01
Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors (NCT00084461)National Cancer Institute (NCI)2004-03-01
Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors (NCT00075439)National Cancer Institute (NCI)2003-12-01
Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu (NCT00004074)National Cancer Institute (NCI)1999-08-01

Track Somatostatinoma automatically

Every clearance here is in the API, with alerts when new ones post.